Efficacy and Safety of Cilostazol for the Indication of CSPS

Clinical trial NCT00216749 · COMPLETED

Trial details

NCT number: NCT00216749
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Study type: OBSERVATIONAL

Cerebral Infarction

Start date: 2003-12-01
Primary completion: 2007-10-01
Enrollment: 650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.